Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28612856 | 1.00 | LMNA (0.35) | LMNACA2CA1MMP1MMP2 | |
| SCHEMBL810661 | 1.00 | LMNA (0.35) | LMNACA2CA1MMP1MMP2 | |
| SCHEMBL3778734 | 1.00 | LMNA (0.35) | LMNACA2CA1MMP1MMP2 | |
| SCHEMBL3770995 | 1.00 | LMNA (0.35) | LMNACA2CA1MMP1MMP2 | |
| SCHEMBL811215 | 1.00 | LMNA (0.35) | LMNACA2CA1MMP1MMP2 | |
| Iodide SCHEMBL3698424 | 0.97 | LMNA (0.33) | LMNACA2 | |
| SCHEMBL5519977 | 0.97 | LMNA (0.30) | LMNA | |
| SCHEMBL4806756 | 0.91 | — | — | |
| SCHEMBL4806917 | 0.91 | — | — | |
| SCHEMBL13738326 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150225339-A1 | FLUORINATED POLYMERIZABLE COMPOUND | BASF SE (DE) | 2015-08-13 | — | — | US | disclosed |
| EP-2904030-A1 | FLUORINATED POLYMERIZABLE COMPOUND | BASF SE (DE) | 2015-08-12 | — | — | EP | disclosed |
| WO-2014053636-A1 | FLUORINATED POLYMERIZABLE COMPOUND | BASF SE (DE) | 2014-04-10 | — | — | WO | disclosed |
| US-20100324205-A1 | FLUID, FLUORINE-CONTAINING AND SINGLE-COMPONENT COMPOSITION | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2010-12-23 | — | — | US | disclosed |
| US-20090240004-A1 | FUNCTIONALIZED POLYURETHANE RESIN, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2009-09-24 | — | — | US | disclosed |
| US-20090198000-A1 | Liquid fluorine-containing and two-component compositions for the surface treatment of mineral and non-mineral substrates | EVONIK DEGUSSA GMBH (DE) | 2009-08-06 | — | — | US | disclosed |
| EP-2085442-A1 | Compounds containing fluoride with improved surface characteristics | Evonik Degussa GmbH (DE) | 2009-08-05 | — | — | EP | disclosed |
| US-20090054588-A1 | Fluoride-modified additive for cementitious products, process for its preparation and use thereof | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2009-02-26 | — | — | US | disclosed |
| EP-1994068-A1 | FLUORINE-MODIFIED ADDITIVE FOR CEMENTITIOUS PRODUCTS, PROCESS FOR ITS PREPARATION AND USE THEREOF | Construction Research and Technology GmbH (DE) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007104494-A1 | FLUORINE-MODIFIED ADDITIVE FOR CEMENTITIOUS PRODUCTS, PROCESS FOR ITS PREPARATION AND USE THEREOF | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2007-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150225339-A1 | FLUORINATED POLYMERIZABLE COMPOUND | FRK, AFF2, AFF1 | LMNA 2867/4885CA2 1277/4885CA1 607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.